Role of NRA in Promoting GMP-compliant Blood Management Practices - The Chinese Taipei Experience-
|
|
- Phoebe Underwood
- 5 years ago
- Views:
Transcription
1 3rd APEC Blood Supply Chain Policy Forum Role of NRA in Promoting GMP-compliant Blood Management Practices - The Chinese Taipei Experience- Ying-Hua (Ellen), Chen Section Chief / GMP Inspector GMP Inspectorate 9 Dec 衛生福利部食品藥物管理署 Food and Drug Administration, Ministry of Health and Welfare
2 Outline National Blood System Policy, Legislation, coordination strategies & program Structure Centralized Blood Service System Inspection on Blood Establishments Promoting GMP-compliant Moving Forward Conclusion 2016/12/9 2
3 National Blood System Policy To ensure the safety, quality, accessibility and timely availability of blood and blood products to meet patients needs. Legislation Blood & Plasma Derivatives Act (2005) Medical Care Act, Pharmaceutical Affairs Act, and etc. Coordinated Blood strategies and Program Ensure effective operation of voluntary non-remunerated donations system. Ensure the safety and quality of blood and blood products. Promote self-sufficiency in blood and blood Products. 2016/12/9 3
4 Structure of National Blood System to be organized and coordinated at national level (MoHW) Ministry of Health and Welfare (MoHW) Nation Blood Policy Advisory Committee Representative from DoMA, CDC, FDA, NHIA & Ministry of economic Affair; Experts from Taiwan Society of Blood Transfusion, Medical Doctors, Professional etc. Taiwan Blood Services Foundation (TBSF) Chaired by Vice Minister of MoHW Executive Secretary: Taiwan FDA Face to face meeting: twice a year 2016/12/9 4
5 Centralized Blood Service System TBSF is regulated as health & medical care institution meet the requirements of Standards for Blood Establishments Blood centers (incl. Blood stations, Labs, Collection sites) are inspected against PIC/S GMP Guide & national regulations, and authorized by MoHW Reference: 2016/12/9 5
6 Outline National Blood System Inspection on Blood Establishments Objectives & Scope Competent Authority Quality Standards Inspection Procedures Promoting GMP-compliant Moving Forward Conclusion 2016/12/9 6
7 Inspection on Blood Establishments Objectives & Scope To prevent the transmission of infectious disease; To ensure the safety and Quality of blood, Blood components & PdMPs. Whole Blood patients Blood centers, stations Blood collection TBSF Donation Blood Components Storage, Distribution Plasma derived medicinal products (PdMPs) Collection sites (incl. Mobile units) Testing, Processing Plasma (recovered/source) Plasma Fractionator 2016/12/9 7
8 Inspection on Blood Establishments Competent Authority MoHW Nation Blood Policy Advisory Committee 2016/12/9 8
9 GMP Inspectorate MoHW Taiwan FDA Division of Risk Management GMP/GTP/GDP/GLP Inspectorate Pharmaceutical GMP Inspection and Licensing System has been established based on: PIC/S Recommendations(PI 002-3) ICH Q10, ICH Q9 ISO 9001:2008, ISO 19011:2002, ISO17020:1998 Competent inspectors Qualification & training Quality manual, SOPs, work instructions 2016/12/9 9
10 A member of PIC/S Taiwan FDA was accepted by PIC/S Committee as the 43th (6th in Asia) PIC/S Participating Authority starting on Jan. 1, 2013 Training opportunity Rapid Alert System International GMP harmonization Information sharing Networking 2016/12/9 10
11 Inspection on Blood Establishments Quality standards International GMP standards - PIC/S GMP Guide 2016/12/9 11
12 ASEAN MRA on GMP inspection 2016/12/9 12
13 Adopted PIC/S GMP since 2006 Bilingual version of GMP Guide 2016/12/9 13
14 Structure of PIC/S GMP Guide Part I Basic Requirements for Medicinal Products principles and general requirements for the manufacture of medicinal products Annexes provide detail on specific areas of activity. For some manufacturing processes, different annexes will apply simultaneously Part II Basic Requirements for APIs principles and general requirements for the manufacture of active substances used as starting materials 2016/12/9 14
15 Part I of PIC/S GMP Guide QUALITY MANAGEMENT CONTRACT MANUFACTURE AND ANALYSIS;SELF INSPECTION Input Process output MATERIALS PREMISES & EQUIPMENT PERSONNEL PRODUCTION SM FP Validation, Prevention of cross-contamination, MIX-UP Release COMPLAINTS PRODUCT RECALL DOCUMENTATION QUALITY CONTROL 2016/12/9 15
16 Annexes of PIC/S GMP Guide Annex 1 Manufacture of Sterile Medicinal Products Annex 2 Manufacture of Biological Active Substances and Medicinal Products Annex 3 Manufacture of Radiopharmaceuticals Annex 4 Manufacture of Veterinary Medicinal Products other than Immunological Veterinary Medicinal Products Annex 5 Manufacture of Immunological Veterinary Medicinal Products Annex 6 Manufacture of Medicinal Gases Annex 7 Manufacture of Herbal Medicinal Products Annex 8 Sampling of Starting and Packaging Materials Annex 9 Manufacture of Liquids, Creams and Ointments Annex 10 Manufacture of Pressurised Metered Dose Aerosol Preparations for Inhalation Annex 11 Computerised Systems Annex 12 Use of Ionising Radiation in the Manufacture of Medicinal Products Annex 13 Manufacture of Investigational Medicinal Products Annex 14 Manufacture of Products derived from Human Blood or Human Plasma Annex 15 Qualification and validation Annex 17 Parametric Release Annex 19 Reference and Retention Samples 2016/12/9 16
17 2016/12/9 17
18 other Guidance 2016/12/9 18
19 1. DOCUMENT HISTORY 2. INTRODUCTION 3. PURPOSE 4. SCOPE 2016/12/9 5. QUALITY MANAGEMENT 6. PERSONNEL 7. PREMISES 8. EQUIPMENT 9. DOCUMENTATION 10.DONOR SESSIONS 11.COMPONENT PREPARATION 12.STORAGE AND DISPATCH 13.QUALITY MONNITORING 14.LABORATORY TESTING 15.COMPLAINS AND RECALL 16. REFERENCES 17. RELEVANT TERMINOLOGY 18. REVISION HISTORY 19
20 Inspection on Blood Establishments Inspection Procedures Be routinely inspected every 3 years (2011, 2014, 2017) Unannounced inspections may be performed, if necessary Inspection team GMP inspectors of Taiwan FDA External experts (Medical Doctors & Medical Technologist) in the filed Blood transfusion, Hematology, Blood banks operation, Laboratory of biochemistry, Medical Laboratory Science and Biochemistry Pre-inspection A master file of BE and related documents are submited. Pre-inspection meetings with inspection team To discuss the scope (blood Center, stations, collection sites, mobile units), focus and depth of inspection To prepare the inspection plan (including the inspection agenda and aide-memoir ) Notification of the inspection to BEs 2016/12/9 20
21 Inspection on Blood Establishments Inspection procedures Conduct inspection Takes an average of 3-4 days Typically conducted by 3-4 inspectors & 4 external experts Issue Exit Notice (list of observations) Post-inspection GMP inspection report will be issued to the BEs BEs need to submit CAPAs Inspection team assess the CAPAs Re-inspection may be performed, if necessary Close the inspection/ Extend the manufacturing license Notify any substantial change to Taiwan FDA for approval Depended on the change, approval by dossier verification or on-site inspection. In 2016, four on-site inspection were conducted 2016/12/9 21
22 Outline National Blood System Inspection on Blood Establishments Promoting GMP-compliant Leverage the international resources Training for inspectors & industry Work together with Blood Establishments Moving Forward Conclusion 2016/12/9 22
23 Promoting GMP-compliant Leverage the International Resources PIC/S Expert Circle Work together with Blood Establishments TBSF Training for Inspectors Training for Industry
24 Promoting GMP-compliant Leverage the International Resources Pharmaceutical Inspection Co-operation Scheme (PIC/S) An informal co-operative arrangement between Regulatory Authorities in the field of GMP of medicinal products To lead the international development, implementation and maintenance of harmonized GMP standards and Quality Systems of inspectorates in the field of medicinal products Providing training opportunities to inspectors. Facilitating co-operation and networking between competent authorities, regional and international organizations, thus increasing mutual confidence. Partners: EDQM, EMA, UNICEF, WHO 2016/12/9 24
25 PIC/S comprised 49 Participating Authorities from all continents Applicants (5) : Brazil / ANVISA Iran / IFDA Mexico / COFEPRIS Philippines / PFDA Turkey / TMMDA Pre-Applicants (3) Belarus / MoH Chile / ISP Kazakhstan / CCMPA EU Member States (27), Europe: Switzerland, Norway, Iceland, Liechtenstein, Ukraine America: Canada, USA, Argentina Asia: Singapore, Malaysia, Israel, Indonesia, Chinese Taipei, Korea, Japan, HK, Thailand Oceania: Australia, New Zealand Africa: South Africa 2016/12/9 25
26 PIC/S Expert Circles To enable Inspectors to discuss and exchange information on specific technical areas of GMP; To develop draft guidance documents & jointly revise the EU/PICS GMP Guide; To provide for training opportunities in their field of expertise Currently active EC Active Pharmaceutical Ingredients, Human Blood, Tissues, Cells & ATMPs Computerized Systems, Good Distribution Practice, Quality Risk Management only open to inspectors from PIC/S members, (Pre-)Applicants, Partners and Non-Member NRA. Nor open to Industry. 2016/12/9 26
27 PIC/S EC on Human Blood, Tissues, Cells & ATMPs Mandate of the EC (valid 2 years after adopted on July 2016) To hold experts' discussions and training of Inspectors in the field of blood, blood components, plasma derivatives, cells and tissues with particular focus on ATMPs; To finalize guidelines and aide memoires developed by the previous EC and develop guidelines and aide memoires on new topics such as ATMPs; PIC/S GMP guidance for blood establishments (PE-005-3) to be revised and harmonized with EU Good Practices Guidelines for blood establishments, and EUBIS inspection guide to be used as a source for new items in the revision To map competences of PIC/S members with particular focus on the inspection of products manufactured in the field human blood, tissues and cells (including ATMPs). 2016/12/9 27
28 PIC/S EC meeting 2016 in HK 2015 in Rome 2013 in Taipei Program: Presentations, Workshops, Blood Establishments tour 2016/12/9 28
29 Promoting GMP-compliant Training for Inspectors Training activities from PIC/S International Seminars/conferences Observations of inspections In-house study groups 2016 IPFA Asia Pacific Workshop in Taipei - Plasma Quality and Supply 2016/12/9 29
30 Promoting GMP-compliant Training for Industry TFDA organizes GMP seminar/workshops free open to pharmaceutical industry (incl. Blood Establishments) every year Budgets from Taiwan FDA; Co-organized with associations (PDA-TW chapter, TPQRI ) 2016/12/9 30
31 Promoting GMP-compliant Work together with BEs Knowledge flows between inspectors and operators in BEs during inspection TBSF
32 Outline National Blood System Inspection on Blood Establishments Promoting GMP-compliant Moving Forward Conclusion 2016/12/9 32
33 Moving Forward Keep updating and harmonizing the regulation system & quality standards internationally Actively participating the PIC/S Expert Circle on Human Blood, Tissues, Cells & ATMPs Join the WG on revision of PIC/S GMP guidance for blood establishments (PE-005-3) Continual training on competent inspectors trained in specificity of the blood processing Training both theoretical and on site (mock inspection by experienced inspector, PIC/S training) Keep promoting GMP-compliant of BEs 2016/12/9 33
34 Revision of PIC/S GMP guidance for blood establishments (PE-005-3) To be continued after the meeting in HK this October A working group is going to be formed to further review and complete the Guide. Several attendees volunteered to participate to a drafting group To be harmonized with EU Good Practices Guidelines for blood establishments, and EUBIS inspection guide to be used as a source for new items in the revision An advanced revised draft to be presented and discussed during the next EC meeting 2016/12/9 34
35 Outline National Blood System Inspection on Blood Establishments Promoting GMP-compliant Moving Forward Conclusion 2016/12/9 35
36 Conclusion The Quality Journey is a Voyage, NOT a Destination! We re Committed to our Quality Journey Better Together! Consumer Protection Win-Win Government Smart Administration Blood Establishments Competences 2016/12/9 36
37 Thank You for Your Attention Chiang Kai-shek Memorial Hall Taipei 101 Yehliu Geopark Sun Moon Lake North-East coast of Taiwan Pingxi Flying Lanterns Penghu Night Markets Temples For more information: Website is at /12/9 37
Heng-Jung Lien 衛生福利部食品藥物管理署. Section Chief. Food and Drug Administration, Ministry of Health and Welfare
Heng-Jung Lien Section Chief Division of Medicinal Products, Food and Drug Administration, Ministry of Health and Welfare, Taiwan, R.O.C. 衛生福利部食品藥物管理署 Food and Drug Administration, Ministry of Health and
More informationValidation Introduction. Presented by John Montalto 27 March, 2013
Validation Introduction Presented by John Montalto 27 March, 2013 John Montalto Bachelor of Science Management Diploma >15 years of Industry Experience Consultant to United Nations various Government Regulatory
More information2010/SOM3/LSIF/032 LSIF Initiatives Medical Devices Global Regulatory Harmonization and Anti-Counterfeit Medicines Global Cooperation
2010/SOM3/LSIF/032 LSIF Initiatives Medical Devices Global Regulatory Harmonization and Anti-Counterfeit Medicines Global Cooperation Submitted by: United States Life Sciences Innovation Forum Sendai,
More informationSingle market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations Brussels,
More informationUpdate from FDA Office of Regulatory Affairs
Update from FDA Office of Regulatory Affairs Ellen F. Morrison Assistant Commissioner for Medical Products and Tobacco Operations Office of Regulatory Affairs U.S. Food and Drug Administration 1 The Impact
More informationGLP in the European Union Ecolabel detergents, GLP and accreditation
GLP in the European Union Ecolabel detergents, GLP and accreditation Maik Schmahl Brussels, 25/03/2010 Chemicals Unit Outline What is GLP? How has it developed? The role of the Member States, the European
More informationPIC/S GUIDANCE ON CLASSIFICATION OF GMP DEFICIENCIES
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 040-1 3 Appendices 1 January 2019 PIC/S GUIDANCE ON CLASSIFICATION OF GMP DEFICIENCIES PIC/S January 2019 Reproduction
More informationGMP IN BLOOD ESTABLISHMENTS: A BASIC ELEMENT FOR PLASMA QUALITY
GMP IN BLOOD ESTABLISHMENTS: A BASIC ELEMENT FOR PLASMA QUALITY Dr. Christian Schärer Swissmedic, Swiss Agency for Therapeutic Products Inspectorates, Hallerstrasse 7 CH-3000 Bern 9 christian.schaerer@swissmedic.ch
More informationREGIONAL ALLIANCE FOR NATIONAL REGULATORY AUTHORITIES FOR VACCINES IN THE WESTERN PACIFIC. second edition
REGIONAL ALLIANCE FOR NATIONAL REGULATORY AUTHORITIES FOR VACCINES IN THE WESTERN PACIFIC second edition World Health Organization 2014 The designations employed and the presentation of the material in
More informationSingapore s Progress on GLP and MAD
2010/SOM1/CD/WKSP/025 Agenda Item: Afternoon Session I Singapore s Progress on GLP and MAD Submitted by: Singapore Case Study Workshop on the Chemicals Sector - From Principles to Practice Hiroshima, Japan
More informationEU Regulatory Update & GMP Deficiencies. Bryan J Wright July 2017
EU Regulatory Update & GMP Deficiencies Bryan J Wright July 2017 Slide 1 PharmOut 2017 Outline Update on changes in EU GMP Guide Summary of GMP changes to the Guide Important details of changes over the
More information(Adopted by the Committee of Ministers on 19 January 2011 at the 1103rd meeting of the Ministers Deputies)
Resolution CM/ResAP(2011)1 on quality and safety assurance requirements for medicinal products prepared in pharmacies for the special needs of patients (Adopted by the Committee of Ministers on 19 January
More informationTGA regulation of local manufacturers of plasma derivatives CSL Behring Australia s overview
IPFA Workshop Session 7: REGULATORY CONSIDERATIONS TGA regulation of local manufacturers of plasma derivatives CSL Behring Australia s overview Mary Lavithis, CSL Behring Australia Presented at: IPFA Asia
More informationPharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.
1 International International Conference on Harmonization (ICH) World Health Organization (WHO) 2 Argentina National Administration of Drugs, Food and medical Technology. Australia s Department of health
More informationEssential Medicines. WHO
12 Health Technology and Pharmaceuticals Participants to the Workshop on Pharmaceutical Policies and Access to Good Quality Essential Medicines for Pacific Island Countries observing pharmaceutical services
More information2015/LSIF/FOR/009 Securing Political and Financial Support for Blood Safety - Philippine Experience
2015/LSIF/FOR/009 Securing Political and Financial Support for Blood Safety - Philippine Experience Submitted by: Philippines 2 nd APEC Blood Supply Chain Policy Forum Anaheim, United States 23 October
More informationMalaysia s Experience in Regulating the Medical Device Sector
2011/SOM1/SCSC/CON1/012 Session 7 Malaysia s Experience in Regulating the Medical Device Sector Submitted by: Malaysia 6 th Conference on Good Regulatory Practice Washington, D.C., United States 1-2 March
More informationJoint FAO/WHO Food Standards Programme Food and Agriculture Organization of the United Nations Lusaka, Zambia, 3-5 July 2002
FAO/WHO CODEX ALIMENTARIUS COMMISSION (CODEX) Joint FAO/WHO Food Standards Programme Food and Agriculture Organization of the United Nations Lusaka, Zambia, 3-5 July 2002 1. Introducing Codex Alimentarius
More informationGlobal EHS Resource Center
Global EHS Resource Center Understand environmental and workplace safety requirements that affect your global operations. 800.372.1033 bna.com/gelw Global EHS Resource Center This comprehensive research
More informationRegional Activities Department
Regional Activities Department Annual Meeting of the OIE Regional and Sub-Regional Representations PARIS, OIE Headquarters, 22 25 October 2013 Dr François CAYA, Head of the Department RAD Team (Oct.2013)
More informationPRODUCT DECLARATION. Purolite C100MRNS. This declaration was prepared by Purolite Corporation in February, 2017.
PRODUCT DECLARATION Purolite C100MRNS This declaration was prepared by Purolite Corporation in February, 2017. Prepared by: Doina Florea Quality & Regulatory Manager Cosmin Catanas Quality Assurance Engineer
More informationSummary and Recommendations - APEC Dialogue on Avian Influenza Risks in the Live Bird Market System (LBMS)
2008/ATCWG12/031 Agenda Item: XII Summary and Recommendations - APEC Dialogue on Avian Influenza Risks in the Live Bird Market System (LBMS) Purpose: Information Submitted by: United States 12 th Agricultural
More informationATMPs & EU GMP Update. Bryan J Wright July 2017
ATMPs & EU GMP Update Bryan J Wright July 2017 Slide 1 PharmOut 2017 Outline ATMPs What they are? Why are we looking at this subject? The Licensing position of ATMPs and use of PRIME ATMPs and GMP Inspections
More informationPRODUCT DECLARATION. Purolite A430MR. This declaration was prepared by Purolite Corporation in February, 2017.
PRODUCT DECLARATION Purolite A430MR This declaration was prepared by Purolite Corporation in February, 2017. Prepared by: Doina Florea Quality & Regulatory Manager Cosmin Catanas Quality Assurance Engineer
More informationHealth Task Force Workplan
2006/SOM 3/HTF/021 Agenda Item: VI Health Task Force Workplan 2006-2007 Purpose: Information Submitted by: Chair Health Task Force Meeting Da Nang, Viet Nam 14 15 September 2006 APEC HEALTH TASK FORCE
More informationIPEC Europe Suggested Alternative (if none then original text is clear and needs no alteration) Purpose and Scope
IPEC Europe Observations and Recommendations on Guidelines On The Formalised Risk Assessment For Ascertaining The Appropriate Good Manufacturing Practice For Excipients Of Medicinal Products For Human
More informationIndian Pharmacopoeia Commission
Indian Pharmacopoeia Commission JP 130 th Anniversary Symposium Tokyo, Japan 15 th Sept, 2016 Dr.G.N.Singh Secretary cum Scientific Director, Overview Indian Pharmaceutical Industry Pharmacopoeia and NFI
More informationAGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014)
AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION (Moscow, 23 December 2014) Member States of the Eurasian Economic Union, hereinafter referred
More informationJOSEFIEN VENDRIK, QUALITY MANAGER IRENE JONGENELEN, COÖRDINATOR CLINICAL SUPPLIES MANAGEMENT/ SENIOR CLINICAL STUDY MANAGER
Food for Thought JOSEFIEN VENDRIK, QUALITY MANAGER IRENE JONGENELEN, COÖRDINATOR CLINICAL SUPPLIES MANAGEMENT/ SENIOR CLINICAL STUDY MANAGER CLINOPS DAG, 12 APRIL 2018 HISTORY OF RESEARCH AND DEVELOPMENT
More informationPromoting Public Health Dialogue between Asia and Europe
Promoting Public Health Dialogue between Asia and Europe ASEF Public Health Network Joint ECDC and ASEF workshop How can we be better prepared for the next global health threat? Planning and implementing
More informationREGULATORY CHALLENGES IN SOUTH AFRICA
REGULATORY CHALLENGES IN SOUTH AFRICA MEDICINES CONTROL COUNCIL SA Prof Peter Eagles Chairperson Medicines Control Council [Southern African Regional and International Symposium (SARI 2014)] 1 OUTLINE
More informationThe Trilateral FTA: A Pillar of Trilateral Cooperation and East Asia Economic Integration
The Trilateral FTA: A Pillar of Trilateral Cooperation and East Asia Economic Integration 2012.10.23 (TUE) North-East Asia Forum on Trade and Transport Facilitation 1 CONTENTS 1. Significance of Trilateral
More information14 th International Conference of Drug Regulatory Authorities : Progress report from the Western Pacific Region
14 th International Conference of Drug Regulatory Authorities : Progress report from the Western Pacific Region Budiono Santoso Team Leader Essential Medicines & Technologies, World Health Organization,
More informationYuppadee JAVROONGRIT, Ph.D.
Plenary 4- Collaboration & Cooperation among Regulatory Agencies Recent Developments in Cooperation of Regulatory Authorities among ASEAN countries by Yuppadee JAVROONGRIT, Ph.D. Assistant Director, Drug
More informationWork plan for the joint CHMP/ CVMP Quality Working Party (QWP) for 2018
4 December 2017 EMA/CHMP/CVMP/QWP/504882/2017 Committee for Medicinal Products for Human Use (CHMP) Committee for Medicinal Products for Veterinary Use (CVMP) Work plan for the joint CHMP/ CVMP Quality
More informationGLOBAL BIOANALYSIS CONSORTIUM
GLOBAL BIOANALYSIS CONSORTIUM Scope and Regulations Harmonization Team: A1 (Work in Progress) John Smeraglia on behalf of the HT-A1 A1: Scope and regulations Team members: Team lead Region Expertise Surendra
More informationNew Zealand Government Oversight of Halal Certification of Animal Products Exported from New Zealand Auckland University Asia Dialogue July 2012
New Zealand Government Oversight of Halal Certification of Animal Products Exported from New Zealand Auckland University Asia Dialogue July 2012 Kathy Lloyd Market Access Counsellor www.mpi.govt.nz New
More informationPandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits: report of the Advisory Group
EXECUTIVE BOARD 130th session 20 December 2011 Provisional agenda item 6.9 Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits: report of the Advisory
More informationHaemovigilance in Europe: What do health authorities expect from haemovigilance?
Haemovigilance in Europe: What do health authorities expect from haemovigilance? Deirdre Fehily Substances of Human Origin Team Directorate General for and Food Safety Unit B4 Products: quality, safety
More informationCross Contamination & the EU GMP Guide. Bryan J Wright July 2017
Cross Contamination & the EU GMP Guide Bryan J Wright July 2017 Slide 1 PharmOut 2017 Outline PICs GMP (v13) and Cross Contamination (CC) EU GMP Guide changes to Chapters 3 & 5 Other related EU regulatory
More informationPRODUCT DECLARATION. Purolite C115KMR. This declaration was prepared by Purolite Corporation in February, 2017.
PRODUCT DECLARATION Purolite C115KMR This declaration was prepared by Purolite Corporation in February, 2017. Prepared by: Doina Florea Quality & Regulatory Manager Cosmin Catanas Quality Assurance Engineer
More informationGlobal Best Practices in Tobacco Control
Global Best Practices in Tobacco Control Samira Asma, DDS, MPH Chief, Global Tobacco Control Centers for Disease Control and Prevention Regional Consultation on Multisectoral Policies for Prevention and
More informationThe Initiative Project on the Guideline of Understanding Framework on the Veterinary Profession in ASEAN (GUFVA2014)
Faculty of Veterinary Science, Chulalongkorn University 26 June 2014 The Initiative Project on the Guideline of Understanding Framework on the Veterinary Profession in ASEAN (GUFVA2014) Assist/Prof Suchit
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
SOP details SOP title: SOP number: SOP category: Version number: 03 Version date: 19 December 2016 Effective date: 19 January 2017 Revision due date: 19 January 2020 NEWCASTLE CLINICAL TRIALS UNIT STANDARD
More informationGLP Update and Hot Topics
GLP Update and Hot Topics RQA Annual Conference Mark Goodwin 9 Nov 2016 Introduction International GLP Updates OECD including MAD Agreement EC/ EMA US FDA & US EPA UK GLP Update MHRA MHRA GLP Deficiencies
More informationOfficial Journal of the European Union L 8/29
13.1.2007 Official Journal of the European Union L 8/29 COMMISSION DECISION of 22 December 2006 as regards certain protection measures in relation to highly pathogenic avian influenza and movements of
More informationSperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ
CHAPTER 8: Donation Although there has been a reduction in the use of donor sperm because of ICSI and the impact of the removal of anonymity in some countries (1), sperm donation is still used and has
More informationEconomic and Social Council
United Nations E/CN.3/2018/22 Economic and Social Council Distr.: General 14 December 2017 Original: English Statistical Commission Forty-ninth session 6 9 March 2018 Item 4 (b) of the provisional agenda*
More informationEPIDEMIOLOGY. Accurate, in-depth information for understanding and assessing targeted markets
EPIDEMIOLOGY Accurate, in-depth information for understanding and assessing targeted markets WHY ACCURATE MARKET FORECASTS Start with accurate understanding Epidemiology is the study of disease patterns
More informationGeneral Information Booklet on the ASEAN Harmonised Cosmetic Regulatory Scheme
asean General Information Booklet on the ASEAN Harmonised Cosmetic Regulatory Scheme Ten Nations One Community www.aseansec.org Association of Southeast Asian Nations General Information Booklet on the
More informationDONOR RECRUITMENT AND PLASMA COLLECTION IN INDONESIA. Yuyun SM Soedarmono Blood Services Committee Ministry of Health of Indonesia 1
DONOR RECRUITMENT AND PLASMA COLLECTION IN INDONESIA Yuyun SM Soedarmono Blood Services Committee Ministry of Health of Indonesia 1 OUTLINE Introduction Challenges to Fulfill Global Demand of Plasma for
More informationPlasma for fractionation: South African Plasma Requirements
Plasma for fractionation: South African Plasma Requirements Dr Jeh-han Omarjee Head: Microbiological Sciences NBI is a "not for profit" company committed to providing safe, cost effective, quality medicinal
More informationMomentous gathering of the dental industry DenTech China 2017 The 21 st China International Exhibition & Symposium on Dental Equipment, Technology &
Momentous gathering of the dental industry DenTech China 2017 The 21 st China International Exhibition & Symposium on Dental Equipment, Technology & Products, successfully held in Shanghai, China from
More informationOverview Consumer Health Products Law and Compliance Issues
Overview Consumer Health Products Law and Compliance Issues The First Asia Pacific Pharmaceutical Compliance Congress September 2011 CHONG JIN NG Assistant General Counsel Asia Shared Legal Services Consumer
More information(WP)/ICP/IVD/1.1/001-A Report series number: RS/2011/GE/63(KOR) REPORT
(WP)/ICP/IVD/1.1/001-A Report series number: RS/2011/GE/63(KOR) English only REPORT FIRST WORKSHOP FOR NATIONAL REGULATORY AUTHORITIES FOR VACCINES IN THE WESTERN PACIFIC REGION Seoul, Korea 9-11 vember
More informationTowards a Sustainable Global Infrastructure for Medical Countermeasures
Towards a Sustainable Global Infrastructure for Medical Countermeasures Institute of Medicine The Public Health Emergency Medical Countermeasures Enterprise: Innovative Strategies to Enhance Products from
More informationWHAT DO MANUFACTURERS AND IMPORTERS HAVE TO DO TO PREPARE FOR EU MEMBERSHIP?
WHAT DO MANUFACTURERS AND IMPORTERS HAVE TO DO TO PREPARE FOR EU MEMBERSHIP? pharmaceutical regulatory affairs consulting and education www.rapharm.eu Vesna Koblar, MD. PhD. EU28: Science, Medicines, Health
More informationOrnsurang Teerawat
ASEAN TRADITIONAL MEDICINES AND HEALTH SUPPLEMENTS REGULATORY AND HARMONIZATION UPDATE Ornsurang Teerawat 21.10.2014 \ http://trainstudenytp.wordpress.com ACCSQ (ASEAN Consultative Committee for Standard
More informationINDO-AFRICA PHARMA BUSINESS MEET
INDO-AFRICA PHARMA BUSINESS MEET AYUSH Exports & Potentials by: Ranjit Puranik, Chief Executive Officer, Shree Dhootapapeshwar Limited Overall Exports from ASU&H Industry Economic region wise Export Analysis
More informationMHRA Pharmacovigilance System Master File (PSMF) Inspection Findings
MHRA Pharmacovigilance System Master File (PSMF) Inspection Findings Gretel Sakyi Medical Information and Patient Safety Manager AstraZeneca UK 07 June 2018 Agenda MHRA inspections How inspectors use the
More informationThe OIE World Animal Health and Welfare Fund
The OIE World Animal Health and Welfare Fund Alain Dehove (DVM, MSc) Coordinator of the OIE World Fund a.dehove@oie.int OIE World Animal Health & Welfare Fund Created in 2004 by a resolution voted by OIE
More informationTerms and Conditions. VISA Global Customer Assistance Services
Terms and Conditions VISA Global Customer Assistance Services Visa Global Customer Assistance Services (VGCAS) 1 The Visa Global Customer Assistance Services are co-ordinated by the Global Assistance Centre
More informationquality and safety of pharmacy preparations in Europe
quality and safety of pharmacy preparations in Europe Henk Scheepers, Pharm D, Senior-Inspector Public Health Supervisory Service Health Care Inspectorate The Netherlands 1 Nothing to disclose 2 1 quality
More informationEVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL TEXTS FOR USE IN THE ICH REGIONS ON DISINTEGRATION TEST GENERAL CHAPTER Q4B ANNEX 5(R1)
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL
More informationProgress of Expert Working Group on ESM (EWG)
Workshop 2015 of the Asian Network for Prevention of Illegal Transboundary Movement of Hazardous Wastes 23-25 November 2015, Singapore Progress of Expert Working Group on ESM () Michikazu Kojima Institute
More informationRecommended composition of influenza virus vaccines for use in the 2007 influenza season
Recommended composition of influenza virus vaccines for use in the 2007 influenza season September 2006 This recommendation relates to the composition of vaccines for the forthcoming winter in the southern
More informationDisclaimer. The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be
Ending the Myths: Best Practice in Trial Conduct in Latin America Katie Margules Global Vice President Alliance Management Covance Disclaimer The views and opinions expressed in the following PowerPoint
More informationEPA REGULATORY UPDATE
SOCIETY OF QUALITY ASSURANCE REGULATORY FORUM EPA REGULATORY UPDATE Linthicum Heights, Maryland January 24, 2008 Robert Cypher United States Environmental Protection Agency 2/13/2008 SQA Baltimore 1 ANY
More informationMHRA Pharmacovigilance Inspections: Prepare and Manage for Success
MHRA Pharmacovigilance Inspections: Prepare and Manage for Success Created and Presented by Miranda Dollen Vice President, Pharmacovigilance & EEA QPPV Mapi 2016, All Rights Reserved 2 Prepare and Manage
More informationNATIONAL BLOOD TRANSFUSION SERVICES STRATEGY
FEDERAL DEMOCRATIC REPUBLIC OF ETHIOPIA MINISTRY OF HEALTH NATIONAL BLOOD TRANSFUSION SERVICES STRATEGY February 2005 Addis Ababa Ethiopia Acknowledgement The Ministry of Health of the Federal Democratic
More informationCHAPTER 4 POST-MARKETING SURVEILLANCE OF DRUGS
CHAPTER 4 POST-MARKETING SURVEILLANCE OF DRUGS Post-marketing surveillance (PMS) to assure the quality, efficacy and safety of drugs after they go on the market and to establish proper methods of use of
More informationIndustry s Perspective on the Status of Medical Device Regulations. FUNDISA Workshop 09 & 10 Oct Anele Vutha SAMED Regulatory Committee
Industry s Perspective on the Status of Medical Device Regulations FUNDISA Workshop 09 & 10 Oct 2014 Anele Vutha SAMED Regulatory Committee Today s Topics: 1. Medical Device Definition - Differences 2.
More informationOverview Internal review
Overview Internal review Presentation title: QRM, It s not all about the assessment Track title: Day 1, Session 2 Speaker: Seamus Orr Date / Time: 10 August 2015, 14.30 15.00 Time allotted: 30 minutes
More informationPersonnel. Women in the Secretariat. Report by the Director General
Board of Governors General Conference GOV/2017/39-GC(61)/19 Date: 2 August 2017 General Distribution Original: English For official use only Item 8(b)(ii) of the Board s provisional agenda (GOV/2017/33)
More informationEconomic and Social Council
United Nations Economic and Social Council Distr.: General 13 September 2013 ECE/WG.1/2013/4 Original: English Economic Commission for Europe Working Group on Ageing Sixth meeting Geneva, 25-26 November
More informationA high-level overview of the requirements of medical packaging standards
Medical Packaging A high-level overview of the requirements of medical packaging standards Dec 2012 Thierry Wagner Regulatory Affairs Director Europe, Middle East and Africa DuPont Medical & Pharmaceutical
More informationQuality Assurance Policy. for the. Procurement of HIV Point-of-Care Technology. under the UNITAID Grant
Quality Assurance Policy for the Procurement of HIV Point-of-Care Technology under the UNITAID Grant UNICEF Supply Division Quality Assurance Centre and Health Technology Centre Revisions Version Date
More informationWorkshop for OIE national Focal Points for Veterinary Products November 2010, Johannesburg, South Africa. Presentation
Dr. Anja Holm Chair of CVMP, EMA Danish Medicines Agency Copenhagen, DK - Denmark anh@dkma.dk Overview of existing structures relevant for Veterinary Products Regional Structures: Europe European Medicine
More informationNew Annex 15 Updated Requirements & Approach to Validation. Presented by Ashley Isbel 10 th August 2015
New Annex 15 Updated Requirements & Approach to Validation Presented by Ashley Isbel 10 th August 2015 EU GMP Guide Annex 15 Qualification & Validation 2001 Current version of Annex 15 published Nov 2012
More informationProgress on Implementation of Global FMD Control
Progress on Implementation of Global FMD Control Part II. Joseph Domenech OIE,Paris 41 th General Session of the European Commission for the control of Foot and Mouth Disease (EuFMD) 23-24 th April 2015,
More informationClinical Trials in Third Countries
Clinical Trials in Third Countries meeting, 29 January 2015 Presented by Fergus Sweeney European Medicines Agency An agency of the European Union Overview Distribution of clinical trials submitted in support
More informationSTERILITY TESTING OF PHARMACEUTICAL PRODUCTS
STERILITY TESTING OF PHARMACEUTICAL PRODUCTS Tim Sandle CONTENTS Introduction xiii 1 STERILITY 1 Introduction 1 Sterility 3 Microorganisms and Microbial Growth 5 Types of microorganisms 7 Sterilization
More informationProcurement policies and requirements
Procurement policies and requirements JOINT UNICEF, UNFPA & WHO meeting with manufacturers, Copenhagen 22-24 Sep 2014 ELODIE JAMBERT International Pharmacist Coordinator Médecins Sans Frontières (MSF)
More informationProgramme. "Quality Control Laboratories: How to Inspect" PIC/S Pre- Seminar and Seminar
PIC/S Pre- Seminar and Seminar "Quality Control Laboratories: How to Inspect" Programme Hosted by Taiwan Food and Drug Administration, Ministry of Health and Welfare 11-15 September 2017 Grand Victoria
More information2004, OIE initiative Ad hoc Group on Antigen & Vaccine Banks for FMD
2004, OIE initiative Ad hoc Group on Antigen & Vaccine Banks for FMD 2006, progressed by EU Funded project 2009, endorsed at OIE/FAO Global Conference on FMD, Paraguay In May 2010, Dr Jef Hammond presented
More informationPlasma Fractionation Issues for Developing Countries DR YASMIN AYOB
Plasma Fractionation Issues for Developing Countries DR YASMIN AYOB Plasma Fractionation Evolved from a medical service to a global manufacturing industry Involves sophisticated industrial process High
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL GUIDELINES and FORMS TABLE OF CONTENTS 1 Guidelines and Forms 1.01 Index to Guidelines and Forms 2 Human Medicines 2.01 General information 2.02 Pharmaceutical and Analytical
More informationMary Frances Lowe U.S. Codex Office World Spices Congress Kochi, India February 16-19, 2014
Mary Frances Lowe U.S. Codex Office World Spices Congress Kochi, India February 16-19, 2014 1 What is the Codex Alimentarius Relationship between Codex and WTO Agreements Principles and Values International
More informationExploring Investments in Meat and Poultry Plants in the USA
Exploring Investments in Meat and Poultry Plants in the USA An introduction as to how the GCC, Arab/Muslim Countries can have control of stunning and slaughtering processes. A Presentation By: Habib A.
More informationDIRECTIVES. (Text with EEA relevance)
L 238/44 DIRECTIVES COMMISSION DIRECTIVE (EU) 2017/1572 of 15 September 2017 supplementing Directive 2001/83/EC of the European Parliament and of the Council as regards the principles and guidelines of
More informationPPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM
HEMATOLOGY ONCOLOGY PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM COMMITTED TO ADVANCING DRUG DEVELOPMENT IN ONCOLOGY $ MARKETPLACE COMPLEXITIES increasingly competitive marketplace and rising cost pressures
More information1. Avian Influenza H5N1 had not occurred in Malaysia until the first case of
INTERVENTION NOTES BY H.E. AMBASSADOR HAMIDON ALI, PERMANENT REPRESENTATIVE OF MALAYSIA TO THE UNITED NATIONS AT THE SPECIAL EVENT ON THE THEME OF AVIAN FLU, ORGANIZED BY THE ECONOMIC AND SOCIAL COUNCIL
More informationREGULATORY AFFAIRS UNIVERSITY JOINS INDUSTRY - BARCELONA MARCH 15 TH, 2017 GALENICUM REGULAOTRY AFFAIRS 1
REGULATORY AFFAIRS UNIVERSITY JOINS INDUSTRY - BARCELONA MARCH 15 TH, 2017 GALENICUM REGULAOTRY AFFAIRS 1 Introduction Regulatory Affairs-Europe Regulatory Affairs-other markets Career development & personal
More informationShort Range Outlook for Steel Demand Autumn OECD Steel Committee, Paris, 10 December Short Range Outlook overview
Short Range Outlook for Steel Demand Autumn 29 OECD Steel Committee, Paris, 1 December 29 Content Short Range Outlook overview Background of the Forecast Regional overviews Conclusion 2 1 Short Range Outlook
More informationJOINT STATEMENT OF ASEAN PLUS THREE HEALTH MINISTERS SPECIAL MEETING ON EBOLA PREPAREDNESS AND RESPONSE Bangkok, Thailand, 15 December 2014
JOINT STATEMENT OF ASEAN PLUS THREE HEALTH MINISTERS SPECIAL MEETING ON EBOLA PREPAREDNESS AND RESPONSE Bangkok, Thailand, 15 December 2014 We, the Health Ministers of Brunei Darussalam, Cambodia, Indonesia,
More informationReport by the Convention Secretariat. Purpose of the document
66 Conference of the Parties to the WHO Framework Convention on Tobacco Control Eighth session Geneva, Switzerland, 1 6 October 2018 Provisional agenda item 6.5 FCTC/COP/8/10 27 June 2018 Progress report
More informationBlanka Hirschlerová. EDQM CEP conference Prague, Czech Republic
1 Experience with CEPs from a European regulatory authority perspective Blanka Hirschlerová EDQM CEP conference Prague, Czech Republic 2012 STATE INSTITUTE FOR DRUG CONTROL Agenda 2 Agenda Introduction
More informationWorldwide Regulatory Perspective on Herbal Drugs & Herbal formulations
Dr.Mohan Krishna.,M.Pharm.,Ph.D professor Krishna Teja Pharmacy College Tirupathi Worldwide Regulatory Perspective on Herbal Drugs & Herbal formulations 2 Terminology Herbal Substances are mainly whole,
More informationTuberculosis. Ruth McNerney
Tuberculosis African and interregional harmonization activities to improve access to affordable IVD Ruth McNerney London School of Hygiene & Tropical Medicine Department of Pathogen Molecular Biology,
More informationAccelerating the Pace of Chemical Risk Assessments
Accelerating the Pace of Chemical Risk Assessments An International Workshop Hosted by the US EPA September 14-15, 2016 in Washington DC Robert Kavlock, US EPA European Commission Scientific Conference
More information